Max Schottelius: Pioneer in Pheochromocytoma.

J Endocr Soc

Section for Preventive Medicine, University Medical Center, Albert Ludwigs University, 79106 Freiburg, Germany.

Published: July 2017

First descriptions of diseases attract tremendous interest because they reveal scientific insight even in retrospect. Max Schottelius, the pathologist contributing the first histological description of pheochromocytoma, remains anonymous. We reviewed the description by Schottelius and weighed the report in modern context. Schottelius described the classical diagnostic elements of pheochromocytoma, including the brown appearance after exposure to chromate-containing Mueller's fixative. This color change, known as chromaffin reaction, results from oxidation of catecholamines and is reflected in the name pheochromocytoma, meaning dusky-colored chromate-positive tumor. Thus Schottelius performed the first known histochemical contribution to diagnosis, which is today standard with immunohistochemistry for chromogranin.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689150PMC
http://dx.doi.org/10.1210/js.2017-00208DOI Listing

Publication Analysis

Top Keywords

max schottelius
8
schottelius pioneer
4
pheochromocytoma
4
pioneer pheochromocytoma
4
pheochromocytoma descriptions
4
descriptions diseases
4
diseases attract
4
attract tremendous
4
tremendous interest
4
interest reveal
4

Similar Publications

The liquid-to-solid phase transition is a complex process that is difficult to investigate experimentally with sufficient spatial and temporal resolution. A key aspect of the transition is the formation of a critical seed of the crystalline phase in a supercooled liquid, that is, a liquid in a metastable state below the melting temperature. This stochastic process is commonly described within the framework of classical nucleation theory, but accurate tests of the theory in atomic and molecular liquids are challenging.

View Article and Find Full Text PDF

Influence of corticosteroid treatment on CXCR4 expression in DLBCL.

EJNMMI Res

May 2023

Translational Radiopharmaceutical Sciences, Department of Nuclear Medicine and Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), University of Lausanne, Rue du Bugnon 25A, Agora, CH-1011, Lausanne, Switzerland.

Background: CXCR4-targeted radioligand therapy (RLT) with [Lu]Lu/[Y]Y-PentixaTher has recently evolved as a promising therapeutic option for patients with advanced hematological cancers. Given their advanced disease stage, most patients scheduled for PentixaTher RLT require concomitant or bridging chemotherapy to prevent intermittent tumor progression. These (mostly combination) therapies may cause significant downregulation of tumoral CXCR4 expression, challenging the applicability of PentixaTher RLT.

View Article and Find Full Text PDF

Crystallization is a fundamental process in materials science, providing the primary route for the realization of a wide range of new materials. Crystallization rates are also considered to be useful probes of glass-forming ability. At the microscopic level, crystallization is described by the classical crystal nucleation and growth theories, yet in general solid formation is a far more complex process.

View Article and Find Full Text PDF

Max Schottelius: Pioneer in Pheochromocytoma.

J Endocr Soc

July 2017

Section for Preventive Medicine, University Medical Center, Albert Ludwigs University, 79106 Freiburg, Germany.

First descriptions of diseases attract tremendous interest because they reveal scientific insight even in retrospect. Max Schottelius, the pathologist contributing the first histological description of pheochromocytoma, remains anonymous. We reviewed the description by Schottelius and weighed the report in modern context.

View Article and Find Full Text PDF

We present a cryogenic source of periodic streams of micrometer-sized hydrogen and argon droplets as ideal mass-limited target systems for fundamental intense laser-driven plasma applications. The highly compact design combined with a high temporal and spatial droplet stability makes our injector ideally suited for experiments using state-of-the-art high-power lasers in which a precise synchronization between the laser pulses and the droplets is mandatory. We show this by irradiating argon droplets with multi-terawatt pulses.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!